How should a patient on methimazole with a TSH of 74 mIU/L be managed?

Immediately Stop Methimazole and Start Levothyroxine Replacement

A TSH of 74 mIU/L in a patient on methimazole indicates severe iatrogenic hypothyroidism from methimazole overtreatment—this is a medical emergency requiring immediate discontinuation of the antithyroid drug and initiation of thyroid hormone replacement.

Immediate Management

Stop methimazole immediately. The drug has caused profound hypothyroidism, as evidenced by the markedly elevated TSH 1. Methimazole can cause hypothyroidism necessitating routine monitoring of TSH with dosing adjustments to maintain euthyroidism 1.

Assess symptom severity:

• Grade 3-4 symptoms (severe symptoms, bradycardia, hypothermia, altered mental status suggesting myxedema): Requires hospital admission, endocrinology consultation, and consideration of IV levothyroxine 2
• Grade 2 symptoms (moderate symptoms but able to perform activities of daily living): Can be managed outpatient with oral levothyroxine
• Grade 1 or asymptomatic: Still requires treatment given TSH >10 mIU/L 2

Levothyroxine Initiation

Dosing strategy depends on patient age and cardiac status:

• Patients <50-60 years without coronary heart disease: Start full replacement dose of approximately 1.6 mcg/kg/day based on ideal body weight 3

• Patients >70 years, frail, or with cardiac disease/multiple comorbidities: Start low at 25-50 mcg daily and titrate up gradually 2, 3

Critical caveat: If there is any uncertainty about whether this is primary versus central hypothyroidism (check free T4 to confirm—low TSH with low FT4 suggests central hypothyroidism), hydrocortisone must be given before thyroid hormone to avoid precipitating adrenal crisis 2, 3.

Monitoring and Follow-up

• Recheck TSH and free T4 in 6-8 weeks after starting levothyroxine 2, 3
• Goal: TSH within normal reference range (0.3-4.5 mIU/L)
• Free T4 may normalize faster than TSH, which can lag 2
• Once stable, monitor every 6-12 months or with symptom changes 2

Why This Happened

This represents methimazole-induced hypothyroidism from excessive dosing. The 2011 ATA/AACE guidelines emphasize that when thyroid hormone levels normalize during methimazole therapy, doses should be reduced by 50% or more to maintain euthyroidism 4. The "block and replace" regimen (continuing high-dose methimazole while adding levothyroxine) is generally discouraged due to higher adverse event rates 4.

Reassessing the Original Hyperthyroidism

Once the patient recovers from iatrogenic hypothyroidism:

• If this was Graves' disease being treated with methimazole: Consider whether the patient has achieved remission (typical course is 12-18 months) 4. If TSH normalizes after stopping methimazole and remains normal, the patient may be in remission
• If hyperthyroidism recurs: Consider definitive therapy with radioactive iodine or thyroidectomy rather than restarting methimazole 4
• If continuing methimazole is necessary: Use the lowest effective dose with close TSH monitoring every 4-6 weeks initially 2

Common Pitfalls to Avoid

• Do not continue methimazole at any dose with TSH this elevated
• Do not delay levothyroxine while waiting for methimazole to "wear off"—the drug's effects can persist, and the patient needs active treatment
• Do not miss central hypothyroidism—always check free T4 alongside TSH; if FT4 is also low with "normal" or low TSH, this suggests pituitary/hypothalamic disease requiring different management 2
• Do not start full-dose levothyroxine in elderly or cardiac patients—this can precipitate angina or arrhythmias 3